SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
01-Jun-23 4:29 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 01-Jun-23 | Disposition | 109,459 | -- | -- | (100%) 109.46K to 0 | |
13-Dec-22 8:26 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 13-Dec-22 | Sale (Planned) | 4,752 | $1.06 | $5,041.87 | (2%) 237.47K to 232.72K | |
13-Dec-22 8:26 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 12-Dec-22 | Sale (Planned) | 4,586 | $1.10 | $5,040.01 | (2%) 242.06K to 237.47K | |
13-Dec-22 8:26 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 09-Dec-22 | Sale (Planned) | 4,461 | $1.13 | $5,040.93 | (2%) 246.52K to 242.06K | |
09-Dec-22 4:53 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 08-Dec-22 | Sale (Planned) | 4,014 | $1.26 | $5,041.58 | (2%) 258.47K to 254.46K | |
09-Dec-22 4:53 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 07-Dec-22 | Sale (Planned) | 3,928 | $1.28 | $5,039.62 | (1%) 262.4K to 258.47K | |
07-Dec-22 7:56 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 06-Dec-22 | Sale (Planned) | 3,778 | $1.33 | $5,039.85 | (1%) 273.64K to 269.86K | |
07-Dec-22 7:56 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 05-Dec-22 | Sale (Planned) | 3,686 | $1.37 | $5,049.82 | (1%) 277.33K to 273.64K | |
05-Dec-22 7:52 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 02-Dec-22 | Planned Option Sale | 3,636 | $1.39 | $5,054.04 | (2%) 189.22K to 185.58K | |
05-Dec-22 7:52 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 01-Dec-22 | Option Exercise | 95,385 | -- | -- | 102% 93.83K to 189.22K | |
10-Dec-21 4:34 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 09-Dec-21 | Option Exercise | 43,000 | $0.74 | $31,820.00 | 1098% 3.92K to 46.91K | |
10-Dec-21 4:34 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 31-Aug-21 | Grant | 164 | $14.26 | $2,338.64 | 4% 3.75K to 3.92K | |
08-Mar-21 8:20 AM View: | Tcr2 Therapeutics Inc. (TCRR) | 28-Feb-21 | Grant | 708 | $16.12 | $11,416.10 | 23% 3.04K to 3.75K | |
08-Mar-21 8:20 AM View: | Tcr2 Therapeutics Inc. (TCRR) | 31-Aug-20 | Grant | 1,118 | $10.10 | $11,289.60 | 58% 1.93K to 3.04K | |
27-Mar-20 4:13 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 28-Feb-20 | Grant | 1,082 | $10.10 | $10,928.20 | 128% 0.84K to 1.93K | |
27-Mar-20 4:13 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 30-Aug-19 | Grant | 843 | $12.75 | $10,748.20 | 100% 0 to 0.84K |